Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Biomed Research International|October 7, 2021
The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell CarcinomaJishuai Zhang, Haifeng Wang, Haitao Wu, et al.Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 21, 2007
Altered gene expression in articular chondrocytes of Smad3(ex8/ex8) mice, revealed by gene profiling using microarraysHao Wang, Jishuai Zhang, Qiang Sun, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 31, 2018
Unilateral congenital malformations of middle ear with intact external ear: a review of 64 casesChaoying Tang, Jishuai Zhang, Shiming Yang, et al.Dalton Transactions (Cambridge, England : 2003)|July 22, 2022
Dual-platination and induced oxidation of uridine by a photoactivatable diazido Pt(IV) anticancer prodrugFang Gao, Jishuai Zhang, Xiaoqin Wu, et al.Journal of Infection in Developing Countries|April 16, 2026
Impact of COVID-19 on the treatment outcomes of secretory otitis mediaJishuai Zhang, Weihao Zhao, Ting Zhang, et al.Developmental Biology|July 19, 2005
Smad4 is required for the normal organization of the cartilage growth plateJishuai Zhang, Xiaohong Tan, Wenlong Li, et al.Frontiers in Cell and Developmental Biology|November 11, 2021
A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma PatientsXiangwei Zhang, Wei Dong, Jishuai Zhang, et al.International Journal of Medical Sciences|June 18, 2014
MicroRNA-365 inhibits vascular smooth muscle cell proliferation through targeting cyclin D1Peng Zhang, Cuiying Zheng, Hui Ye, et al.Rapid Communications in Mass Spectrometry : RCM|September 26, 2018
Selective binding of an organoruthenium complex to G-rich human telomeric sequence by tandem mass spectrometryYiyu Cheng, Wenjuan Zeng, Yang Cheng, et al.Experimental Hematology & Oncology|October 27, 2024
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignanciesYingling Zu, Quan Ren, Jishuai Zhang, et al.Pageof 5